Riik: Austraalia
keel: inglise
Allikas: Department of Health (Therapeutic Goods Administration)
ursodeoxycholic acid, Quantity: 250 mg
GM Pharma International Pty Ltd
Ursodeoxycholic acid
Capsule
Excipient Ingredients: silicon dioxide; Gelatin; titanium dioxide; maize starch; magnesium stearate
Oral
100
(S4) Prescription Only Medicine
Ursodeoxycholic acid is indicated in the treatment of chronic cholestatic liver diseases.
Visual Identification: White hard gelatine capsules. The content - white or almost white powder; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius
Licence status A
2017-04-20